173 related articles for article (PubMed ID: 22310934)
1. Hippocampal drebrin loss in mild cognitive impairment.
Counts SE; He B; Nadeem M; Wuu J; Scheff SW; Mufson EJ
Neurodegener Dis; 2012; 10(1-4):216-9. PubMed ID: 22310934
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
[TBL] [Abstract][Full Text] [Related]
3. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
[TBL] [Abstract][Full Text] [Related]
4. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.
Scheff SW; Price DA; Ansari MA; Roberts KN; Schmitt FA; Ikonomovic MD; Mufson EJ
J Alzheimers Dis; 2015; 43(3):1073-90. PubMed ID: 25147118
[TBL] [Abstract][Full Text] [Related]
5. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease.
Reese LC; Laezza F; Woltjer R; Taglialatela G
J Neurochem; 2011 Nov; 119(4):791-804. PubMed ID: 21883216
[TBL] [Abstract][Full Text] [Related]
9. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
10. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
12. Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life.
Aoki C; Sherpa AD
Adv Exp Med Biol; 2017; 1006():119-139. PubMed ID: 28865018
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
14. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
15. White matter disruption at the prodromal stage of Alzheimer's disease: relationships with hippocampal atrophy and episodic memory performance.
Rémy F; Vayssière N; Saint-Aubert L; Barbeau E; Pariente J
Neuroimage Clin; 2015; 7():482-92. PubMed ID: 25685715
[TBL] [Abstract][Full Text] [Related]
16. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
Alegret M; Cuberas-Borrós G; Vinyes-Junqué G; Espinosa A; Valero S; Hernández I; Roca I; Ruíz A; Rosende-Roca M; Mauleón A; Becker JT; Castell-Conesa J; Tárraga L; Boada M
J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal plasticity during the progression of Alzheimer's disease.
Mufson EJ; Mahady L; Waters D; Counts SE; Perez SE; DeKosky ST; Ginsberg SD; Ikonomovic MD; Scheff SW; Binder LI
Neuroscience; 2015 Nov; 309():51-67. PubMed ID: 25772787
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer's disease.
Hirjak D; Wolf RC; Remmele B; Seidl U; Thomann AK; Kubera KM; Schröder J; Maier-Hein KH; Thomann PA
Hippocampus; 2017 Jun; 27(6):702-715. PubMed ID: 28281317
[TBL] [Abstract][Full Text] [Related]
19. Frontal Cortex and Hippocampal γ-Secretase Activating Protein Levels in Prodromal Alzheimer Disease.
Perez SE; Nadeem M; Malek-Ahmadi MH; He B; Mufson EJ
Neurodegener Dis; 2017; 17(6):235-241. PubMed ID: 28743126
[TBL] [Abstract][Full Text] [Related]
20. Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study.
Beauchet O; Launay CP; Sekhon H; Montembeault M; Allali G
Exp Gerontol; 2019 Jan; 115():55-61. PubMed ID: 30447261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
